Applied Research On The Value Evaluation Of X Pharmaceutical Company In Merger And Acquisition By The Income Value Method

Merger and acquisition is an important means for enterprises to realize their own rapid development. It is also an important means of effective allocation of national resources. In recent years, the state takes a series of policies and measures to promote the implementation of mergers and acquisitions between enterprises in China. For both parties, the value evaluation of M & A enterprises is an important issue to determine whether the merger is successful or not. Therefore, the value of M & A enterprises has become the focus of the academic community.The pharmaceutical industry has its own characteristics. Therefore, the evaluation of enterprise value in M & A is different from the general enterprise. It is necessary to consider the risk of its existence and make sure that it can reflect the true value of M & A enterprises. Based on the background of A company merger X pharmaceutical company, this paper studies the value of the enterprise merger and acquisition activity in the pharmaceutical industry by using the present value method. In the process of the research, according to the characteristics of pharmaceutical enterprises, the traditional present value method is adjusted to make it more accord with the pharmaceutical enterprise merger and acquisition activity.This paper first introduces the development status of pharmaceutical glucose industry. Through the analysis of the production status, demand status, price, and enterprise situation of the pharmaceutical glucose production, it has a basic understanding of the development of the pharmaceutical and glucose industry. At the same time, through the introduction of the macro environment and industry competition environment, the development prospect of the whole pharmaceutical glucose industry is analyzed. In recent years, with the continuous expansion of the size of the pharmaceutical glucose industry, the pharmaceutical glucose industry has more and more mergers and acquisitions. Through mergers and acquisitions, it can break through the pharmaceutical glucose industry into barriers, improve enterprise efficiency, form scale economy, and become the market leader. Once again, Through the introduction of A Limited Share Ltd and X Pharmaceutical Company Limited, this paper expounds the motivation of the M & A, namely, to realize the synergy development and obtain the competitive advantage. Finally, this paper studies the application of the income value method in X Pharmaceutical Co., ltd. The value of X Pharmaceutical Co., Ltd was calculated by using the free cash flow forecast. The discount rate correction is to ensure that the value of X Pharmaceutical Co., Ltd. accurate. In the course of the study, the enterprise financial leverage adjusts the risk factor for the special risk of the enterprise. The result can reflect the value of X Pharmaceutical Co., Ltd., which is a good foundation for the enterprise merger and acquisition.